Bloomios, Inc. (BLMS)
Chart Events
Performance Outlook
| Previous Close | 0.9000 |
| Open | 0.9000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.9000 - 0.9000 |
| 52 Week Range | 0.5310 - 2.7900 |
| Volume | |
| Avg. Volume | 2,648 |
| Market Cap | 12.826M |
| Beta (5Y Monthly) | -4.81 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1680 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Bloomios Appoints Industry Veteran, Joe Reid, as Chief Manufacturing Officer
Bloomios, Inc. (the "Company") (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, has appointed Upexi's former production division operations head, Joe Reid, as chief manufacturing officer of Bloomios' wholly owned subsidiary, Bloomios Private Label.
- PR Newswire
Bloomios Completes $23.5 Million Acquisition of Leading Gummy Manufacturer
Bloomios, Inc. (the "Company") (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, has acquired Infusionz, a wholly-owned subsidiary of Upexi (NASDAQ: UPXI).
- PR Newswire
Upexi Announces Sale of Select CBD Assets for $23.5 Million
Upexi Inc. (NASDAQ: UPXI) (the "Company" or "Upexi"), a multi-faceted Amazon and Direct to Consumer brand owner and innovator in aggregation, today announced the sale of select CBD assets to Bloomios, Inc. (OTC: BLMS) for approximately $23.5 million.
